Thus clinical trials on combined effect of ATRi and radiotherapy or chemotherapy are urgently needed and are indeed emerging (38, 39) This led us to investigate the efficacy of ATR inhibitors in an ex-vivo system as a translational stepping-stone by using primary tumor specimens from surgical explants of CRC patients with and without ARID1A expression. The gene discussed is ARID1A; the disease is neoplasm.